Study of Epithelial Growth Factor Receptor Mutations in Tumor Specimens and Blood Samples From Patients With Non-Small Cell Lung Cancer Enrolled on Clinical Trial CASE-2507 [SUBSTUDY OF 700033409]
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Erlotinib (Primary) ; Docetaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 21 Feb 2013 New trial record